August 5, 2014 / 11:37 AM / 3 years ago

Drugmaker Actavis posts 34 pct rise in revenue

Aug 5 (Reuters) - Generic drug maker Actavis Plc's quarterly revenue rose 34 percent due to strong growth in its North America business.

The company had a net profit of $48.7 million, or 28 cents per share, attributable to shareholders for the second quarter ended June 30.

A year earlier, it had a net loss of $564.8 million, or $4.27 per share.

Excluding items, Actavis earned $3.42 per share in the second quarter.

Revenue rose to $2.67 billion from $1.99 billion, a year earlier. (Reporting by Anjali Rao Koppala in Bangalore; Editing by Kirti Pandey)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below